You Are Leaving Lundbeck.com/US

You have chosen to visit another Lundbeck website or a third-party website, which is provided as a service to you. Lundbeck does not control content on third-party websites and cannot make representations concerning the accuracy of information on every website you visit. Lundbeck is not responsible for the privacy policy of any third-party website. We encourage you to read the privacy policy of every website you visit.

Click here to proceed

Cancel

Contact

Get In Touch

Important U.S. and global contact information below. 

Get in touch with our compliance hotline

Report an adverse drug reaction

Have Questions?

Get in Touch

More from Lundbeck
Investor Relations 

Detailed information related to Lundbeck’s financial performance. 

About Us 

A global pharmaceutical company specialized in brain diseases.

Newsroom

For general U.S. press enquiries, please call 1-866-337-6996